This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.
|
|
- Cleopatra Benson
- 5 years ago
- Views:
Transcription
1 Introduction This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level. Definition: The term "extracts and tinctures" refers to substances that have been extracted from the Cannabis sativa plant. This term does not include synthetic preparations. Examples: o Liquid concentrate (e.g. hash oil, hemp oil, butane honey oil, etc) o CBD oil o Solid concentrate (e.g. shatter, budder) o Edibles (e.g. prepared food products) o Liquids (e.g. marijuana tea;) o Tinctures (e.g. concentrated amounts ingested orally or taken under the tongue) o Topical ointments (lotions, salves, balms applied etc) o Nabiximols (e.g. Sativex ) o Epidiolex o Arvisol The questionnaire will take about minutes to complete. You may return to the questionnaire to amend your responses at any time until the closure of the questionnaire. To commence the questionnaire, you will first be asked to indicate that you agree to WHO data sharing policy. The responses of this questionnaire will be compiled into a report that will be publicly available on the WHO ECDD website. The name of your country may be presented alongside questionnaire data unless you indicate that you wish for your country name to be anonymised in the final report. If you wish to submit any information to the attention of the ECDD Secretariat, you will be invited to upload documents at the end of the questionnaire. We thank you in advance for taking the time to complete this questionnaire.
2 General Information * 1. Focal point contact details Name * 2. Please indicate your country
3 WHO Data Sharing Policy Statement of policy on data sharing Data are the basis for all sound public health actions and the benefits of data sharing are widely recognized, including scientific and public health benefits. Whenever possible, WHO wishes to promote the sharing of health data, including but not restricted to surveillance and epidemiological data. In this connection, and without prejudice to information sharing and publication pursuant to legally binding instruments, by providing data to WHO, the [Ministry of Health][other responsible governmental entity] of [Country]: Confirms that all data to be supplied to WHO (including but not limited to the types listed in Annex 3) hereunder have been collected in accordance with applicable national laws, including data protection laws aimed at protecting the confidentiality of identifiable persons; Agrees that WHO shall be entitled, subject always to measures to ensure the ethical and secure use of the data, and subject always to an appropriate acknowledgement of [Country]: - to publish the data, stripped of any personal identifiers (such data without personal identifiers being hereinafter referred to as the Data ) and make the Data available to any interested party on request (to the extent they have not, or not yet, been published by WHO) on terms that allow noncommercial, not-for-profit use of the Data for public health purposes (provided always that publication of the Data shall remain under the control of WHO); - to use, compile, aggregate, evaluate and analyse the Data and publish and disseminate the results thereof in conjunction with WHO s work and in accordance with the Organization s policies and practices. Except where data sharing and publication is required under legally binding instruments (IHR, WHO Nomenclature Regulations 1967, etc.), the [Ministry of Health][other responsible governmental entity] of [Country] may in respect of certain data opt out of (any part of) the above, by notifying WHO thereof in writing at the following address, provided that any such notification shall clearly identify the data in question and clearly indicate the scope of the opt-out (in reference to the above), and provided that specific reasons shall be given for the opt out. ecddsecretariat@who.int
4 * 3. Please confirm that you agree I agree for the information provided in this questionnaire to be published in a report
5 General cannabis information * 4. Do you have any information about the use of extracts and tinctures of cannabis for any purpose (including medical or non-medical use) in your country? Yes No - you will be directed to the end of the questionnaire
6 Medical use This page will ask you about approved medical use of extracts and tinctures of cannabis only. * 5. At national level, are extracts or tinctures of cannabis legally approved for medical use in your country? Yes No Other (please specify)
7 Medical use: Therapeutic indications
8 6. Please indicate any approved therapeutic indications for the use of extracts and tinctures of cannabis in your country Epilepsy Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury Arthritis Dystonia Huntington s disease Parkinson s disease Tourette s syndrome Glaucoma Anxiety Depression PTSD Schizophrenia /psychosis Alzheimer s disease/ dementia Skin disease Irritable bowel syndrome Inflammatory bowel disease Liver disease Obesity/ diabetes Cancer HIV/AIDS Chronic pain Crohn's disease Attention Deficit Disorder (ADD) None specified Other (please specify)
9 7. Please indicate any symptoms that extracts and tincture of cannabis is approved to treat Acute pain Chronic non-cancer pain Cancer pain Nausea/ vomiting Appetite stimulant Headaches/ migraines Muscle spasms Seizures Sleep problems Alcohol withdrawal symptoms Opioid withdrawal symptoms Palliative care Other (please specify) 8. Please indicate whether there are any permitted marketed products of extracts and tinctures of cannabis Name of marketed product & CBD /THC content (if known): Name of marketed product & CBD /THC content (if known): Name of marketed product & CBD /THC content (if known): Name of marketed product & CBD /THC content (if known): Name of marketed product & CBD /THC content (if known):
10 9. Are there any ongoing approved clinical trials in your country that are developing extracts and tinctures of cannabis for medical use? Yes No Other (please specify) 10. Please indicate product name/ trial number/ study phase of any ongoing trials that are developing products of extracts and tinctures of cannabis for medical use Product name Product name Product name Product name Product name Product name
11 Medical use: Access 11. Do individuals require a prescription to obtain medical extracts and tinctures of cannabis? Yes No N/A Other (please specify) 12. What types of professionals are allowed to prescribe extracts and tinctures of cannabis? Medical doctor / psychiatrist Osteopath Nurse/nurse prescriber Pharmacist Psychologist Physiotherapist Healthcare worker No prescription is required Other (please specify)
12 13. What kinds of settings are approved to legally dispense extracts and tinctures of cannabis in your country? At a doctor's office Pharmacies Online Retail shops Licensed/specialised cannabis dispensaries Hospitals Outpatient clinics Palliative care facilities Nursing homes Other (please specify) 14. If patients use medical extracts and tinctures of cannabis on prescription or recommendation of a health professional, will they be reimbursed for the costs of their medication? Yes, they will be reimbursed by National Health Services Yes, each health insurance company in the country will reimburse the patients Some health insurances do reimburse for the costs, others do not Patients have to make extra health insurance arrangements to be reimbursed No, patients cannot be reimbursed Other (please specify) 15. Are any clinical guidelines used in your country for the prescribing of medical extracts and tinctures of cannabis? No N/A Yes (please specify)
13 16. Is there a regulatory agency in your country that monitors extracts and tinctures of cannabis for medical use? No N/A Yes (please specify) 17. How would you describe the trend in the number of users of extracts and tinctures of cannabis for medical use over the last 3 years? The number has The number has The number has The number has substantially slightly remained the The number has substantially Don't know/ increased increased same slightly reduced reduced unsure Extracts and tinctures of cannabis
14 Medical use: National legislation This section will ask about the general policies in your country towards cannabis-related substances for medical use 18. In the past 3 years, has your country changed its national legislation around access to cannabisrelated substances for medical use? Yes, my country has changed its legislation No, my country has not changed its legislation Extracts and tinctures of cannabis Unknown/ Other (please specify) 19. If yes, what types of legislative changes has your country made for medical use of extracts and tinctures of cannabis? Change to the legal status of medical cannabis Changes to the supply of medical cannabis (e.g. changes in licensing, import or export of products) Changes to access to medical cannabis (e.g. variety in products, therapeutic indications etc) Other (please specify) 20. Is your country currently considering changes to its national legislation around access to cannabis and cannabis-related substances for medical use? Yes, my country is preparing changes in its legislation No, my country is not preparing changes in its legislation Extracts and tinctures of cannabis Unknown/ Other (please specify)
15 21. In your opinion, how do you feel the changed legislation around access to extracts and tinctures of cannabis for medical use would impact / has impacted public health in your country? There would There would be /has be /has been a There would There would be/ has been a slightly There would be/ has been a been a substantially negative negative be/ has been slightly positive substantially positive impact on public impact on no impact on impact on impact on public Don't know/ health public health public health public health health unsure Increased availability for medical use Decreased availability for medical use Please explain your response:
16 Non-medical use The next section will ask you about non-medical use of extracts and tinctures of cannabis in your country. Non-medical use includes both recreational use, and use for self-medication purposes. * 22. On a national level, are extracts and tinctures of cannabis legally available for non-medical use in your country? Yes No Other (please specify) 23. Are extracts and tinctures of cannabis used for cultural, ceremonial, or religious purposes in your country? No Unknown Yes (please specify) 24. Does your country collect prevalence data around the use of extracts and tinctures of cannabis? Yes No N/A Unknown
17 Prevalence of non-medical cannabis use 25. Prevalence of use of extracts and tinctures of cannabis amongst adults ( over 18 years of age) Number (or % of population) used in lifetime Number (or % of population) used in the last year Number (or % of population) used in the past month Year of survey data Prevalence by age group (if known) 26. Prevalence of use of extracts and tinctures of cannabis for non-medical use amongst young people ( below 18 years of age) Number (or % of population) used in lifetime Number (or % of population) used in the last year Number (or % of population) used in the past month Year of survey data Prevalence data by age group (if available)
18 27. How would you describe the number of users extracts and tinctures of cannabis for non-medical use over the last 3 years in your country? There has been a There has been a There has been a There has been a significant increase slight increase in There has been no slight decrease in significant decrease in use use change in use use in use Non-medical use by adults Non-medical use by young people (below age 18) Comments:
19 Public health impact of use: Primary Care 28. Does your country collect data about presentations to primary care settings due to the use of extracts and tinctures of cannabis? Yes No Unsure
20 Primary Care II 29. Number of primary care presentations relating to extracts and tinctures of cannabis Number of presentations relating to substance alone Number of presentations relating to substance in combination with other substances Year of data collection 30. Does your country collect data about presentations to emergency care settings due to the use of extracts and tinctures of cannabis? Yes No Unsure
21 Public health: Emergency settings 31. Number of individuals in the past year presenting to emergency settings relating to the use of extracts and tinctures of cannabis Relating to substance alone: Relating to substance with other substances: Year of data collection 32. Please list the adverse effects presented for extracts and tinctures of cannabis at the emergency room/department Injuries related to impaired driving Injuries related to accidents/falls Prenatal exposure Cannabis use disorders / withdrawal Psychiatric comorbidity Respiratory problems 33. Does your country collect data about presentations to substance misuse treatment settings due to the use of extracts and tinctures of cannabis? Yes No Unsure
22 Public health: Substance misuse treatment 34. Number of individuals in the past year presenting to substance misuse treatment due to extracts and tinctures of cannabis Relating to substance alone Relating to substance and other substances Year of data collection 35. Does your country collect data about calls to poison centres due to the use of extracts and tinctures of cannabis? Yes No Unsure
23 Public health impact: Poison control centres 36. Number of calls to poison control centres due to the use of extracts and tinctures of cannabis Relating to substance alone Relating to substance and other substances: Year of data collection 37. Does your country collect data about cases of impaired driving due to the use of extracts and tinctures of cannabis? Yes No Unsure
24 Public health impact: Impaired driving 38. Number of cases of impaired driving due to extracts and tinctures of cannabis Relating to substance alone Relating to substance with other substances
25 Non-Medical Use: National legislation This section will ask you about your national policies on the non-medical use of cannabis 39. In the past 3 years, has your country changed its national legislation around access to extracts and tinctures of cannabis for non-medical use? Yes, my country has changed its legislation No, my country has not changed its legislation Extracts and tinctures of cannabis Please explain your response: 40. If yes, what types of legislative changes has your country made for non-medical use of extracts and tinctures of cannabis? 41. Is your country currently considering changes to its national legislation around access to extracts and tinctures of cannabis for non-medical use? Yes, my country is preparing changes in its legislation No, my country is not preparing changes in its legislation Cannabis plant and cannabis resin Please explain your response:
26 42. In your opinion, how do you feel the changed legislation around access to extracts and tinctures of cannabis for non-medical use would impact / has already impacted public health in your country? There would be/ There would be/ There would be/ There would be/ has been a has been a There would be/ has been a has been a significantly slightly negative has been no slightly positive significantly negative impact impact on public impact on public impact on public positive impact Don't know/ on public health health health health on public health unsure Increased availability for non-medical use Decreased availability for non-medical use Please explain your response:
27 Additional comments / information In this section, you may provide any additional information that you wish for the WHO Expert Committee to consider. You can provide comments on cannabis substances for medical nonmedical and medical use. You may also wish to upload data or documents for the committee to consider. This may include results of national surveys. For the transmission of sensitive or highly confidential information, please submit these documents directly to the ECDD at ecddsecretariat@who.int 43. Comments 44. File upload Choose File No file chosen 45. File upload Choose File No file chosen 46. File upload Choose File No file chosen
Questionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction
Introduction This is one of five questionnaires that Member States are invited to complete ahead of the 40th WHO Expert Committee on Drug Dependence. This questionnaire will ask you about cannabis plant
More informationMedicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system
Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the
More informationMinnesota. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationMinnesota Medical Cannabis Program. October 24, 2017
Minnesota Medical Cannabis Program October 24, 2017 Agenda: Overview of Minnesota Medical Cannabis Program Conditions, roles, products Laboratory Issues Program Evaluation * indicates a hyper-link to website
More informationMedical vs Recreational Use of Cannabis. 11 th December 2017
1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationPATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:
PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: / / Gender: Male Female Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell: Email: Primary
More informationMINNESOTA S MEDICAL CANNABIS PROGRAM
MINNESOTA S MEDICAL CANNABIS PROGRAM DARIN TESKE LEGAL AND POLICY ADVISOR OFFICE OF MEDICAL CANNABIS AUGUST 25, 2016 2014: MN became 22 nd state with full medical cannabis program Recreational and Medical
More informationOhio s Medical Marijuana Control Program
Ohio s Medical Marijuana Control Program Timeline September 8, 2016 House Bill 523 Effective November 5, 2016 Deadline for first Medical Marijuana Advisory Committee meeting May 6, 2017 Cultivator rules
More informationCity Commission Agenda Cover Memorandum
City Commission Agenda Cover Memorandum Originating Department: Planning & Zoning (PZ) Meeting Type: Regular Agenda Date: 10/10/2017 Advertised: Required?: Yes No ACM#: 21615 Subject: Public Hearing and
More informationINITIAL PATIENT INTAKE FORM
INITIAL PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only.
More informationDecember 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage
December 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage You are probably already getting calls from patients about medical marijuana. You probably have many questions about how it
More informationMedical Marijuana Update Chris Belletieri, DO
Dr. Belletieri has provided no disclosures. Graduated PCOM in 1996 In private practice since 1999 Board Certified in FP since 1999 Program Director of FP residency at Lower Bucks Hospital in Bristol, PA
More informationWHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts
More informationSECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)
Regardless of a student, employee, parent or any individual s status as a medical marijuana license holder, marijuana is not allowed on the premises of the district or in any school vehicle or in any personal
More informationDESCRIPTION DURATION
NAME DESCRIPTION DURATION 5 Basic Cannabis Questions Answered - Leafly 412 5 Differences Between Eating and Smoking Cannabis - Leafly 351 5 Things You Didn't Know About MMJ - Civilized 0 A Short History
More informationNew Mexico. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationThe Legalization of Medical Marijuana and the Impact on the Workplace
The Legalization of Medical Marijuana and the Impact on the Workplace Presented by Cassandra L. Manna Thursday, October 12, 2017 Roetzel & Andress LPA 2016 Before We Get Started... Three Rules Supreme
More informationThe Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association
The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists
More informationCDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only
CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of
More informationThe Department must establish a minimum of three regions within the state for the purpose of granting permits to growers/processors and dispensaries.
PA Medical Marijuana Act 1 The Medical Marijuana Act, Act 16 of 2016, establishes a Medical Marijuana Program within the Department of Health ( Department ). Under this program, patients with a serious
More informationJames McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada
James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into
More informationWelcome to MedWell. MedWell Health and Wellness Centers. Don t live with PAIN Live WELL MedWell. o Newspaper o Referred by.
1 Welcome to MedWell Patient Information Date: Name: Date of Birth: / / Address: City: State: Zip Code: Home Phone: ( ) - Cell Phone: ( ) - Email: Gender: o Male o Female State Drivers License: Social
More informationLEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018
LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018 DISCLAIMER The material presented is general legal information and is not legal advice. Specific
More informationFrom heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016
From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016 OSBA leads the way to educational excellence by serving Ohio s public
More informationIn New York State. Highly Worth It OR Not??? Medical Marijuana. The Truths 3/29/2018. True or False???
Medical Marijuana In New York State Highly Worth It OR Not??? Medical Marijuana True or False??? 1. Providers write prescriptions for medical marijuana true or false 2. Medical marijuana in NYS gives people
More informationPennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum
Pennsylvania House of Representatives Joint Health and Judiciary Committee Hearing Medical Cannabis - Health Care Forum Tuesday, March 24, 2015 Philadelphia, Pennsylvania Testimony offered by: David J.
More informationCBD and Your Health.
CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear
More informationNew York. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New York Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationAct 16 and Medical Cannabis in Pennsylvania
Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health
More informationMOTION FOR A RESOLUTION
European Parliament 2014-2019 Committee on the Environment, Public Health and Food Safety 2.10.2018 2018/2775(RSP) MOTION FOR A RESOLUTION further to Question for Oral Answer B8-0000/2018 pursuant to Rule
More informationMedical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator
Medical Cannabis Program Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator Disclaimer The following information is based upon research of current studies. The Department of Health
More informationORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies
ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies ISSUING BODY: The Ministry of Health published in: the Official
More informationCannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017
Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:
More informationAcknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making
Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response
More informationSupplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.
CAYMAN ISLANDS Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016. A BILL FOR A LAW TO AMEND THE MISUSE OF DRUGS LAW (2014 REVISION) TO INCLUDE CANNABIS EXTRACTS AND
More informationMedical Marijuana. Navigating Medical Marijuana in Workers Compensation
Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers
More informationSubstitute HB 523 Outline
Substitute HB 523 Outline 1. Creates Medical Marijuana Control Commission under the auspice of the Department of Commerce 9 member commission No more than 4 members of the Commission shall be from 1 political
More informationMedical Cannabis Ordinances. Tuesday, December 20, 2016
Medical Cannabis Ordinances Tuesday, December 20, 2016 Pre Amendment 2 Law In 2014, the Florida Legislature passed, and Gov. Rick Scott signed, a bill that attempted to exempt a limited class of individuals
More informationASSEMBLY APPROPRIATIONS COMMITTEE STATEMENT TO. ASSEMBLY COMMITTEE SUBSTITUTE FOR ASSEMBLY, No STATE OF NEW JERSEY DATED: APRIL 5, 2018
ASSEMBLY APPROPRIATIONS COMMITTEE STATEMENT TO ASSEMBLY COMMITTEE SUBSTITUTE FOR ASSEMBLY, No. 3421 STATE OF NEW JERSEY DATED: APRIL 5, 2018 The Assembly Appropriations Committee reports favorably an Assembly
More informationINNOVATING WELLNESS RELIEF
INNOVATING WELLNESS RELIEF When Florida passed the original law that individuals with debilitating medical conditions (as determined by a licensed Florida physician) could be approved to utilize medical
More informationWorkplace Issues Associated with Legalized Marijuana. James B. Yates, Esq., SHRM-SCP, SPHR
Workplace Issues Associated with Legalized Marijuana James B. Yates, Esq., SHRM-SCP, SPHR jbyates@eastmansmith.com Agenda: Nationwide legalization efforts Ohio s medical marijuana law The impact of medical
More informationWhat Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1
June 2017 1 2 What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1 Mark R. Hayes, Director of Legal Services, and Lanny Richmond II, Staff Attorney Introduction In 2016, the
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA MINNESOTA ACADEMY OF PHYSICIAN ASSISTANTS MARCH 18, 2016 TOM ARNESON, MD, MPH MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program
More informationWeeding Through the Workplace Impact of Medical Marijuana
Weeding Through the Workplace Impact of Medical Marijuana Steven T. Boell, Shareholder The Landscape in General Medical Marijuana is Big Business In 2015 estimated legal U.S. cannabis sales were $5.7 billion,
More informationImportant Information
Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:
More informationOREGON MEDICAL MARIJUANA ACT
OREGON MEDICAL MARIJUANA ACT 475.300 Findings. The people of the state of Oregon hereby find that: (1) Patients and doctors have found marijuana to be an effective treatment for suffering caused by debilitating
More informationThe Shifting Federal Regulation of Cannabis Products
The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPennsylvania s Medical Marijuana Act and the Creation of a New Protected Class of Employees. Agenda
Pennsylvania s Medical Marijuana Act and the Creation of a New Protected Class of Employees Presented by: Joshua Schwartz Agenda The Medical Marijuana Act Implementation and Basic Requirements Employment
More informationBe it enacted by the People of the State of Illinois,
SB Enrolled LRB0 0 RPM 0 b AN ACT concerning public health. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section. The Compassionate Use of Medical Cannabis
More informationCurious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD
Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests
More informationMedical Marijuana: Current Policies and Consideration. By Michael Bertaut Healthcare Economist, BCBSLA 2019
1 Medical Marijuana: Current Policies and Consideration By Michael Bertaut Healthcare Economist, BCBSLA 2019 2 What are the States Doing? 10 States and Washington DC have legalized Marijuana for recreational
More informationGlobal Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018
Global Legal Cannabis Market: Size, Trends & Forecasts (2018-2022) September 2018 Global Legal Cannabis Market: Coverage Executive Summary and Scope Introduction/Market Overview Global Market Analysis
More informationMarijuana Guidelines
America s Foremost Insurance Brokerage Network AIG No more than twice per year: Best class if otherwise qualified. Up to twice a month: Standard Non-Tobacco rates More often: Tobacco rates, and maybe rated
More informationA look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
More informationMedical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic
Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial
More informationMaine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014
Maine s Medical Marijuana Law 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014 Medical Marijuana Laws Alaska (1998) Arizona (1996, 2010) California (1996) Colorado (2000) Delaware
More informationQ's &A's of Medical Cannabis in Illinois
WHAT IS CANNABIS? Cannabis, also known as marijuana, is a dynamic plant that has medicinal and therapeutic benefits. Chemical compounds in the plant are called cannabinoids and terpenes work together to
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA EPILEPSY & SEIZURES WELLNESS EXPO APRIL 16, 2016 MICHELLE LARSON, MPA MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program State
More informationOncology Pharmacy Navigator: A Novel Model for Medication Management
Oncology Pharmacy Navigator: A Novel Model for Medication Management Kelly Rice, Pharm.D. Oncology Pharmacy Navigator Legacy Cancer Institute Portland, Oregon Objectives Understand the role of an oncology
More informationMarijuana and the Workplace : Changing Times
Marijuana and the Workplace : Changing Times By: Stéphane Thiffeault 2018 AMCTO Conference Blue Mountain Resort June 12, 2018 Presentation Outline Current Status of Cannabis Some Facts and Statistics Summer
More informationMembership Package Checklist
Membership Package Checklist Name: Date: Phone number: Email: Please check that your membership package includes the following: Application for Registration signed and dated Code of Conduct read, checked
More informationMedical Marijuana Update
Health Services Department Medical Marijuana Update March 7, 2017 Presentation Outline Florida Compassionate Medical Cannabis Act Legalization of Medical Cannabis Amendment 2 Department of Health Rulemaking
More informationRequirement for Certification from a Health Care Practitioner. Requirement for Certification from a Health Care Practitioner
Johnson County Pharmacists Association Current Status of the Iowa Ronald A. Herman, Ph.D. 1 Objectives Identify the current status of Iowa medical cannabis regulations. List the current disease conditions
More informationCannabinoids: access and symptom management in cancer
Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%
More information78th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 964 SUMMARY
Sponsored by Senators BURDICK, KRUSE th OREGON LEGISLATIVE ASSEMBLY-- Regular Session Senate Bill SUMMARY The following summary is not prepared by the sponsors of the measure and is not a part of the body
More information3 By Representatives Ball, Hill (M), Sessions, Martin, Johnson. 5 Sanderford, Todd, Hall, Farley, Daniels, Butler, Fridy, Shedd,
1 HB61 2 172469-2 3 By Representatives Ball, Hill (M), Sessions, Martin, Johnson 4 (K), Wood, Brown, McCutcheon, Hubbard, Williams (JD), 5 Sanderford, Todd, Hall, Farley, Daniels, Butler, Fridy, Shedd,
More informationMEDICAL MARIJUANA: WHAT S THE EVIDENCE?
MEDICAL MARIJUANA: WHAT S THE EVIDENCE? L A U R A A. M A R K L E Y, M D B O A R D - C E R T I F I E D I N P E D I A T R I C S / G E N E R A L P S Y C H I A T R Y / C H I L D & A D O L E S C E N T P S Y
More informationCANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE
1 CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations
More informationCOMIRB Protocol Number: PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH. Dear Fellow Medical Student,
COMIRB Protocol Number: 13-2387 PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH Dear Fellow Medical Student, We are conducting a study to assess the attitudes and experiences of medical
More informationArkansas Municipal League. What Cities Need to Know about the Arkansas Medical Marijuana Amendment
Arkansas Municipal League What Cities Need to Know about the Arkansas Medical Marijuana Amendment «ARKANSAS MUNICIPAL LEAGUE«GREAT CITIES MAKE A GREAT STATE May 2018 What Cities Need to Know about the
More informationWelcome to MedWell. Patient Information. Name: Address: City: State: Zip Code: !Other. Name: Address: City: State:
1 Welcome to MedWell Patient Information Date: Name: Date of Birth: / / Address: City: State: Zip Code: Home Phone: ( ) - Cell Phone: ( ) - Email: Gender:! Male! Female Last 4 of Social Security Number
More informationPLENARY PANEL THE INTERSECTION OF MENTAL HEALTH AND MARIJUANA LEGALIZATION
STANFORD ADOLESCENT MENTAL WELLNESS CONFERENCE: OVERCOMING CULTURAL BARRIERS TO ACCESS PLENARY PANEL THE INTERSECTION OF MENTAL HEALTH AND MARIJUANA LEGALIZATION Time: Friday, April 27, 3:15-4:15p Paula
More informationMedical Cannabis: A Patient Primer
Medical Cannabis: A Patient Primer This primer is meant for documented patients who are using medicinal cannabis or considering using it in the future. The information provided about this medication in
More informationMEMBERSHIP OVERVIEW. To become a member at Warmland, you must provide documentation confirming you fall into at least one of the following categories:
MEMBERSHIP PACKAGE MEMBERSHIP OVERVIEW Welcome to Warmland Medicinal Cannabis Centre. Our aim is to provide a consistent, safe, local and dependable source of medicinal cannabis for people suffering from
More informationMARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec
MARIJUANA in MEDICAL CARE READY or RISKY HINDI MERMELSTEIN, MD FAPM drhmermelstein @optimum.net Beth Israel Medical Center, NYC Dec 11 2015 HISTORY MARIJUANA (CANNABIS SAVITA) HAS LONG BEEN PART OF RELIGIOUS
More informationImportant Information
Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:
More informationACKNOWLEDGEMENTS. VT Cannabis Survey Preliminary Findings: August
ACKNOWLEDGEMENTS Champlain Valley Dispensary and Southern Vermont Wellness would like to thank our patients for sharing their insights, experiences and time. This report would not be possible without you.
More informationObjectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access
Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology
More informationSTATUS OF THE NEW CANNABIDIOL PROGRAM
STATUS OF THE NEW CANNABIDIOL PROGRAM WELCOME Anthony Pudlo, PharmD, MBA, BCACP Vice President of Professional Affairs Iowa Pharmacy Association PRESENTERS Owen Parker, MPH Program Manager Office of Medical
More informationDoes Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana
Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana Carla Lomuscio, LCSW, Betsy Long, MSW and Amy Carver, PharmD Disclosures We have no financial
More informationThe products being taken by children with epilepsy are not the equivalent of the marijuana widely used for recreational purposes.
Epilepsy Foundation of Colorado The Use of Cannabis to Treat Children with Epilepsy Updated February 2016 The use of extracts from marijuana plants (cannabis) to treat children with epilepsy has been in
More informationORDINANCE NO
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF ORLANDO, FLORIDA, RELATING
More informationINITIAL PATIENT INTAKE FORM
INITIAL PATIENT INTAKE FORM Name: (Please, print legibly) Registry ID: Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional
More informationCompassionate Medical Cannabis: What It Means to the Street Officer
Compassionate Medical Cannabis: What It Means to the Street Officer Garrett Berman, Assistant State Attorney Broward County (Florida) State Attorney s Office Detective Luis Lopez Jacksonville (Florida)
More informationDr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE
Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)
More informationUse of Cannabinoids in Medical Practice
Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced
More informationPATIENT QUESTIONNAIRE
PATIENT QUESTIONNAIRE Personal Information Date Name Date of Birth Age Height Weight Gender: Male / Female Address City State / Zip Home Phone Cell phone Work phone E-mail address Do you currently have
More informationPennsylvania s Medical Marijuana Act. William Roark, Esq. HRMM&L
Pennsylvania s Medical Marijuana Act William Roark, Esq. HRMM&L MEDICAL MARIJUANA (MMJ) IN THE U.S. 24 States, D.C. & Guam currently allow some form of MMJ Alaska, Arizona, California, Colorado, Connecticut,
More informationLeading a budding industry into the future
genesispharms.com The foundation of Genesis Pharms is deeply rooted in the belief of the power of cannabis to help and to heal. An extraordinary personal healing experience helped shape Sean and Kassy
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationMedical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.
Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound
More informationOutcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationEducating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationI would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people
I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid
More informationMedical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014
Medical Marijuana and Student Health New England College Health Association Gordon H. Smith, Esq. October 30, 2014 Medical Marijuana Laws Alaska (1998) Arizona (1996, 2010) California (1996) Colorado (2000)
More informationUnderstanding Maine s Medical Marijuana Law
Understanding Maine s Medical Marijuana Law Maine Pharmacy Association May 20, 2011 Background 1999: Maine Medical Marijuana Act passes as initiated bill (I.B.) Authorizes medical use of marijuana for
More informationMedical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids
Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State
More informationMedical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids
Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State
More information